1. Cancers (Basel). 2021 Sep 3;13(17):4449. doi: 10.3390/cancers13174449.

A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal 
Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage 
III Tumors.

Palassin P(1), Lapierre M(1), Pyrdziak S(1), Wagner A(1), Stehle R(1), Corsini 
C(1), Duffour J(1), Bonnet S(1), Boulahtouf A(1), Rodriguez C(1), Ho-Pun-Cheung 
A(2), Lopez-Crapez E(1)(2), Boissière-Michot F(2), Bibeau F(1), Thezenas S(1), 
Elarouci N(3), Selves J(4), Hoffmann JS(4), Roepman P(5), Mazard T(1), Buhard 
O(6), Duval A(6), Jalaguier S(1), Cavaillès V(1), Castet-Nicolas A(1)(7)(8).

Author information:
(1)IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U1194, 
Institut Régional du Cancer de Montpellier, Université de Montpellier, F-34298 
Montpellier, France.
(2)Translational Research Unit, Institut du Cancer de Montpellier, F-34298 
Montpellier, France.
(3)Programme Cartes d'Identité des Tumeurs (CIT), Ligue Nationale Contre Le 
Cancer, F-75013 Paris, France.
(4)Département de Pathologie, IUCT, Institut Universitaire du Cancer de 
Toulouse-Oncopôle, 31059 Toulouse, France.
(5)Agendia NV, 1043NT Amsterdam, The Netherlands.
(6)Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et 
Cancer, Unité Mixte de Recherche Scientifique 938 et SIRIC CURAMUS, INSERM, 
Sorbonne Université, 75012 Paris, France.
(7)Centre Hospitalo-Universitaire Montpellier, Département de Pharmacie 
Clinique, 34295 Montpellier, France.
(8)Unité de Formation et de Recherche des Sciences Pharmaceutiques et 
Biologiques, 34090 Montpellier, France.

Microsatellite instability (MSI) is related to the alteration of mismatch repair 
(MMR) genes and plays a key role in colorectal cancer (CRC) pathogenesis. We 
previously reported that the transcription factor Nuclear Receptor Interacting 
Protein 1 (NRIP1) is involved in sporadic intestinal tumorigenesis. The aim of 
this study was to decipher its role in MSI CRC. By using different mouse models 
and engineered cell lines, we demonstrated that NRIP1 increased MSH2 and MSH6 
MMR gene transcription and mRNA/protein levels. In human CRC cells, NRIP1 
expression was associated with decreased MSI and the hypermutator phenotype, and 
with resistance to chemotherapy drugs. Using a cohort of 194 CRC patients, we 
detected in 22% of the cases a MSI-induced frameshift mutation in the NRIP1 
coding sequence. This genetic alteration generates a truncated protein with a 
dominant negative activity that increased human CRC cell proliferation and 
impaired the regulation of MSH2 and MSH6 gene expression. Moreover, the NRIP1 
mutant correlated with a decreased overall survival of patients with advanced 
CRC, especially when MLH1-deficient. By decreasing the expression of MSH2 and 
MSH6 gene expression, the NRIP1 variant may amplify MLH1-dependent CRC 
progression and behave as a new prognostic marker of advanced MSI CRC.

DOI: 10.3390/cancers13174449
PMCID: PMC8430632
PMID: 34503257

Conflict of interest statement: The authors declare no conflict of interest.